RR6
CAS: 1351758-37-6
Ref. 3D-BEC75837
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
- (2R)-2-Hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide
RR6 is a glycol ether that is used in the treatment of metabolic disorders. It activates AMP-activated protein kinase (AMPK) and inhibits ATP citrate lyase, thereby increasing acetyl-CoA levels and decreasing fatty acid synthesis. RR6 also reduces oxidative stress by inhibiting the production of reactive oxygen species and inhibiting mitochondrial permeability transition pore opening. This drug has been shown to be effective against choroidal neovascularization, which may be due to its ability to reduce vascular endothelial growth factor levels. RR6 is a small molecule that can be administered orally or intravenously, making it an attractive candidate for drug development.
Chemical properties
Technical inquiry about: 3D-BEC75837 RR6
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.